Bristol-Myers Squibb Company
MODIFIED SELF-IMMOLATING MOIETIES FOR USE IN PRODRUGS AND CONJUGATES AND METHODS OF USING AND MAKING

Last updated:

Abstract:

Compounds represented by formula (I) ##STR00001## can be used to make antibody-drug conjugates. The conjugates so made are stable in both human and mouse serum, enabling the performance of pre-clinical studies using a mouse model.

Status:
Application
Type:

Utility

Filling date:

29 May 2019

Issue date:

5 Dec 2019